Myoblast transplantation is a potential treatment for Duchenne Muscular Dystrophy. This article confirms by experiments in mice that one problem that has limited the success of clinical trials of this procedure is a rapid (within 3 days) inflammatory reaction which kills most of the injected myoblasts. The death of the transplanted myoblasts can be prevented by treating the host with a mAb against LFA-1. This led to a 27-fold increase in the number of muscle fibers expressing a reporter gene present in the donor myoblasts when the host is also adequately immunosuppressed with FK506. Therefore, both the nonspecific inflammatory reaction and the specific immune response should be adequately controlled following myoblast transplantation.
AdamM.A.; RameshN.; MillerD.A.; OsborneW.R.A.Internal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions.J. Virol.65: 4895–4990; 1991.
2.
ArithaJ.; SaulS.; JohS.; AtiyaA.; UneS.; OhtsukaS.; MullenY.Islet protective effect of pravastatin from nonspecific inflammation in mouse pancreatic islet isograft.Transplant. Proc.28: 924; 1996.
3.
BeauchampJ.R.; MorganJ.E.; PagelC.N.; PartridgeT.A.Quantitative studies of efficacy of myoblast transplantation.Muscle Nerve Suppl.4: S261; 1994.
4.
BertonG.; LaudannaC.; SorioC.; RossiF.Generation of signals activating neutrophil functions by leukocyte integrins: LFA-1 and gpl50/95, but not CR3, are able to stimulate the respiratory burst of human neutrophils.J. Cell. Biol.116: 1007–1017; 1992.
5.
ColliganJ.E.; KruisbeekA.M.; MarguliesD.H.; ShevachE.M.; StroberW.Current protocols in immunology.New York: Greene Publishing Associates and Wiley-Interscience; 1992: 2.7.1–2.7.11.
6.
EntmanM.L.; SmithC.W.Postreperfusion inflammation: A model for reaction to injury in cardiovascular disease.Cardiovas. Res.28: 1301–1311; 1994.
FlemingT.J.; FlemingM.L.; MalekT.R.1993. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family.J. Immunol.151: 2399–2408; 1993.
9.
GuéretteB.; AsselinI.; VilquinJ.T.; RoyR.; TremblayJ.P.Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice.Muscle Nerve18: 39–51; 1995.
10.
HallauerP.L.; BradshawH.L.; HastingsK.E.M.Complex fiber-type-specific expression of fast skeletal muscle troponin I gene constructs in transgenic mice.Company Biol. Ltd.119: 691–701; 1993.
11.
HestdalK.; RuscettiF.W.; IhleJ.N.; JacobsenS.E.W.; DuboisC.M.; KoppW.C.; LongoD.L.; KellerJ.R.Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.J. Immunol.147: 22–28; 1991.
12.
HuardJ.; AcsadiG.; JaniA.; MassieB.; KarpatiG.Gene transfer into skeletal muscles by isogenic myoblasts.Hum. Gene Ther.5: 949–958; 1994.
KinoshitaI.; VilquinJ.T.; GueretteB.; AsselinI.; RoyR.; TremblayJ.P.Very efficient myoblast allotransplantation in mice under FK-506 immunosuppression.Muscle Nerve17: 1407–1415; 1994.
15.
KinoshitaI.; VilquinJ.T.; TremblayJ.P.Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: Study using mdx/b-galactosidase transgenic mice.Acta Neuropathol.91: 489–493; 1996.
16.
MichaelisD.; GobelsN.; HohlfeldR.Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes.Am. J. Pathol.143: 1142–1149; 1993.
17.
MorganJ.E.; BeauchampJ.R.; PagelC.N.; PeckhamM.; AtaliotisP.; JatP.S.; NobleM.D.; FarmerK.; PartridgeT.A.Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: A model system for the derivation of tissue-specific and mutation-specific cell lines.Dev. Biol.162: 486–498; 1994.
SambrookJ.; FrotsschE.F.I.; ManiatesT.Molecular cloning, 2nd ed.Cold Spring Harbor Ng: Cold Spring Harbor Laboratory Press;1991: 16.66–16.67.
20.
SmithC.W.; MarlinS.D.; RothleinR.; TomanC.; AndersonD.C.Cooperative interactions of LFA-1 and MAC-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.J. Clin. Invest.83: 2008–2017; 1989.
TremblayJ.P.; MalouinF.; RoyR.; HuardJ.; BouchardJ.P.; SatohA.; RichardsC.L.Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.Cell Transplant.2: 99–112; 1993.
